Cargando…
Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial
AIM: To determine whether cytisine was at least as effective as varenicline in supporting smoking abstinence for ≥ 6 months in New Zealand indigenous Māori or whānau (extended‐family) of Māori, given the high smoking prevalence in this population. DESIGN: Pragmatic, open‐label, randomized, community...
Autores principales: | Walker, Natalie, Smith, Barry, Barnes, Joanne, Verbiest, Marjolein, Parag, Varsha, Pokhrel, Subhash, Wharakura, Mary‐Kaye, Lees, Tina, Cubillos Gutierrez, Huber, Jones, Brian, Bullen, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519028/ https://www.ncbi.nlm.nih.gov/pubmed/33761149 http://dx.doi.org/10.1111/add.15489 |
Ejemplares similares
-
Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non‐inferiority trial
por: Walker, Natalie, et al.
Publicado: (2018) -
Effectiveness of nicotine salt vapes, cytisine, and a combination of these products, for smoking cessation in New Zealand: protocol for a three-arm, pragmatic, community-based randomised controlled trial
por: Walker, Natalie, et al.
Publicado: (2023) -
Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023) -
The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial
por: Bullen, Chris, et al.
Publicado: (2018) -
Effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial
por: Walker, Natalie, et al.
Publicado: (2019)